新開源(300109.SZ)半年度淨利潤預增77.83%-117.35%
格隆匯7月13日丨新開源(300109.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤9000萬元-11000萬元,同比增長77.83%-117.35%。業績變動原因如下:
1、報吿期內,公司積極圍繞戰略規劃目標,創新發展,高效、高質推進工作,各業務板塊經營狀況持續向好。消費類特種化學品板塊繼續深挖市場,加大研發投入,同比營業收入、淨利潤取得較大增幅;精準醫療服務業務板塊同比有所增長,腫瘤篩查業務扭虧為盈,分子診斷業務虧損收窄,基因測序業務及生物試劑業務平穩發展。
2、公司於2021年3月26日披露“關於向激勵對象首次授予限制性股票的公吿”,本報吿期業績預吿數據已扣除股權激勵應攤銷成本1527.68萬元。
3、報吿期非經常性損益對淨利潤的影響金額約2200萬元,主要系投資永泰生物所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.